Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT)

84 filings reported holding SGMT - Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share as of Q4 2024.
Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,500,774 shares of 31,278,271 outstanding shares and own 56% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (2,316,572 shares), NEA Management Company, LLC (2,000,275 shares), Blue Owl Capital Holdings LP (1,323,877 shares), Alyeska Investment Group, L.P. (1,290,512 shares), VANGUARD GROUP INC (1,131,127 shares), BlackRock, Inc. (978,723 shares), BAKER BROS. ADVISORS LP (952,996 shares), Rock Springs Capital Management LP (787,808 shares), CITADEL ADVISORS LLC (744,532 shares), and HHLR ADVISORS, LTD. (724,800 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.